Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
Citation
Lidbury, B.A, Kita, B, Lewis, D et al 2017, 'Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study', Journal of Translational Medicine, vol. 15, no. 1.Year
2017ANU Authors
Fields of Research
- Clinical Chemistry (Diagnostics)
- Pathology (Excl. Oral Pathology)
- Epidemiology